Therma Bright Inc. remains stable amid strategic developments.
Therma Bright Inc. (THRM.V) has held steady in its stock performance recently, closing at C$0.04 with no change over the past day. Despite a challenging month, where the stock has decreased by 10%, the company has made notable progress in its operational activities.
Advertisement
Therma Bright Inc
THRM.V
THRM.V
Therma Bright Inc
WealthAwesomeMarket cap
$2.76M
52W high
$0.12
52W low
$0.04
1W change
+0.00%
Beta
1.11
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on THRM's historical volatility
30-Day Vol
131.3%
Annualized
90-Day Vol
98.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.04 | C$0.03 – C$0.07 |
| 60 trading days | C$0.04 | C$0.02 – C$0.08 |
| 90 trading days | C$0.04 | C$0.02 – C$0.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should monitor Therma Bright's strategic partnerships and operational developments as potential indicators of future performance, especially given the recent orders for its Venowave products.
C$0.04 Closing Price with 1D Change of 0.00%
Therma Bright's stock price has remained within 6% of its 52-week low, indicating a period of relative stability amidst broader market concerns.
Bull case
Recent strategic orders and partnerships may indicate a growing demand for Therma Bright's products, which could lead to future revenue growth. The company recently secured a significant commercial order for 100 Venowave™ units with Horizon Health, a key player in durable medical equipment. This follows a successful proof-of-concept phase, showcasing the company's ability to optimize delivery and support protocols in the U.S. market. Additionally, initial orders for its Venowave products highlight continued demand, even in challenging market conditions.
Bear case
On the downside, the company's financial metrics reveal significant challenges. Therma Bright has a high negative return on equity and a declining stock price over the year, which could impact investor confidence. Currently, the stock is trading below both its 50-day moving average of C$0.05 and its 200-day moving average of C$0.06, indicating a downward trend. The stock's beta of 1.11 suggests slightly higher volatility compared to the broader market, which may concern risk-averse investors.
Recent Stock Performance
Therma Bright Inc. has exhibited a stable stock performance, closing at C$0.04 with no change over the past day. Over the last week, the stock has also remained unchanged, but it has seen a decline of 10% over the past month and 18.18% year-to-date. The latest trading volume was 14,000 shares, which is 1.45 times higher than the 20-day average of 31,721 shares, indicating increased interest from investors.
Company Developments
Advertisement
Therma Bright has been active in securing strategic partnerships recently. This includes the recent commercial order for 100 Venowave™ units with Horizon Health, a significant player in durable medical equipment. Following a successful proof-of-concept phase, the company has demonstrated its ability to optimize delivery and support protocols in the U.S. market. Additionally, Therma Bright has received initial orders for its Venowave products, highlighting continued demand despite challenging market conditions.
Technical Picture
From a technical perspective, Therma Bright’s stock is currently trading below both its 50-day moving average of C$0.05 and its 200-day moving average of C$0.06, reflecting a downward trend. The stock has a 52-week range of C$0.04 to C$0.12, with its current price sitting at the lower end of this range. The stock's beta of 1.11 indicates a slightly higher volatility compared to the broader market, which may be a consideration for risk-averse investors.
Insider Activity
Recently, Therma Bright granted incentive stock options to directors, officers, and certain consultants, allowing for the purchase of up to 2,850,000 common shares at C$0.07 per share. This move may indicate management's confidence in the company's future prospects and aligns their interests with those of shareholders.
Conclusion
Therma Bright Inc. closed at C$0.04, reflecting stability in its stock price amidst ongoing operational developments. Investors may want to continue monitoring the company's strategic partnerships and orders for its products, which could signal future growth opportunities.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
